Refine by
Pharmaceutical Articles & Analysis: This-Year
2 articles found
The institute covers roughly half of Croatia’s needs, with about 40% of processed plasma used clinically and 60% allocated to pharmaceutical fractionation.Storage and manufacturing workflowHZTM employs an overnight hold manufacturing process. ...
Outlook In vivo CAR-T remains an emerging modality, but recent clinical progress, academic validation, and major pharmaceutical investment suggest strong long-term potential. As delivery technologies mature, the integration of mRNA engineering, targeted lipid nanoparticles, and functional PEG-lipids is expected to play a defining role in expanding the reach of cell ...